[1]
CrippaS., SalgarelloM., LaitiS., PartelliS., BarugolaG., CastelliP., ZamboniG. and FalconiM. 2012. The Value of 18FDG-PET/CT in Patients with Resectable Pancreatic Cancer: A Prospective Study. JOP. Journal of the Pancreas. 13, 5S (Sep. 2012), 558. DOI:https://doi.org/10.6092/1590-8577/1073.